CD38 and Miyoshi myopathy: A decrease in the level of CD38 in MM cells can occur in several ways: (i) treatment with anti-CD38 mAbs; (ii) generation of MVs followed by their uptake of the CD38-mAb complexes by FcR+-expressing cells; and (iii) trogocytosis (97).